FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk
International Journal of Colorectal Disease, 07/05/2012
Garouniatis A et al. – The results suggest that the selected cellular receptors are suitable for use as biomarkers of survival and tumour progression in colorectal cancer (CRC). Furthermore, the authors provide additional evidence for receptor interaction, properly clarifying their importance, which could potentially lead to more effective anti–CRC regimens.